|
Market Closed -
Nasdaq
00:00:00 03/11/2026 +03
|
5-day change | 1st Jan Change | ||
| 33.63 USD | +4.70% |
|
-0.18% | -19.93% |
| 10-30 | US FDA issues warning on Medline beds after 2 deaths, 16 serious injuries | RE |
| 10-29 | US FDA issues warning on Medline beds after 2 deaths, 16 serious injuries | RE |
| Market Cap | 29.51B 26.34B 24.17B 21.99B 41.23B 2,793B 42.05B 289B 116B 1,474B 111B 108B 4,657B | P/E 2026 * |
45.5x | P/E 2027 * | 29.7x |
|---|---|---|---|---|---|
| Enterprise Value | 39.44B 35.21B 32.31B 29.39B 55.11B 3,734B 56.21B 386B 156B 1,971B 148B 145B 6,225B | EV / Sales 2026 * |
1.26x | EV / Sales 2027 * | 1.13x |
| Free-Float |
66.56% | Yield 2026 * |
0.29% | Yield 2027 * | 0.39% |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| MDLN | Delayed | |
CBOE
| MDLN | Real-time | |
|
BOERSE DUESSELDORF
| L10 | End-of-day quote | |
|
Tradegate
| L10 | Real-time | |
|
Deutsche Boerse AG
| L10 | Delayed | |
|
Boerse Muenchen
| L10 | Real-time | |
|
Xetra
| L10 | Delayed |
Last Transcript: Medline Inc.
| 1 day | +4.70% | ||
| 1 week | -0.18% | ||
| Current month | +4.70% | ||
| 1 month | -5.56% | ||
| 3 months | -14.38% | ||
| 6 months | -24.85% | ||
| Current year | -19.93% |
| 1 week | 31.37 |  | 33.9 |
| 1 month | 31.37 | | 37.02 |
| Current year | 31.37 | | 50.88 |
| 1 year | 31.37 | | 50.88 |
| 3 years | 31.37 | | 50.88 |
| 5 years | 31.37 | | 50.88 |
| 10 years | 31.37 | | 50.88 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/8/26 A | GIC Pte Ltd. (Investment Management)
| Sell | Company | -7,816,987 | 0.8910% | |
| 10/5/26 A | GIC Pte Ltd. (Investment Management)
| Sell | Company | -1,688,690 | 0.1925% | |
| 8/19/26 A | Free | Chief Operating Officer | 87,667 | 0.0119% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.70% | -0.18% | - | - | 29.51B | |
| +3.73% | +5.03% | -10.89% | +14.80% | 191B | |
| +2.85% | +4.75% | +9.47% | +37.73% | 122B | |
| +5.12% | +0.22% | -13.88% | +10.27% | 117B | |
| +0.03% | +2.86% | -41.01% | +7.32% | 96.21B | |
| +2.12% | +2.38% | +0.01% | +75.79% | 64.47B | |
| -5.48% | -5.11% | -1.24% | +61.88% | 52.51B | |
| +0.36% | +1.13% | +11.13% | -22.40% | 54.1B | |
| +21.85% | +17.79% | +6.69% | +60.13% | 52.91B | |
| -0.88% | +4.24% | +1.80% | -10.44% | 35.65B | |
| Average | +0.62% | +3.46% | -4.21% | +26.12% | 81.43B | |
| Weighted average by Cap. | +0.65% | +3.80% | -7.05% | +24.27% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 31.23B 27.88B 25.58B 23.27B 43.63B 2,956B 44.5B 306B 123B 1,560B 117B 115B 4,928B | 33.68B 30.07B 27.59B 25.1B 47.06B 3,188B 47.99B 330B 133B 1,683B 126B 124B 5,315B |
| Net income | 937M 836M 768M 698M 1.31B 88.7B 1.34B 9.17B 3.7B 46.82B 3.52B 3.44B 148B | 1.53B 1.37B 1.26B 1.14B 2.14B 145B 2.19B 15.02B 6.05B 76.69B 5.76B 5.64B 242B |
| Net Debt | 9.94B 8.87B 8.14B 7.4B 13.88B 941B 14.16B 97.23B 39.19B 496B 37.29B 36.49B 1,568B | 8.5B 7.59B 6.96B 6.34B 11.88B 805B 12.11B 83.18B 33.53B 425B 31.9B 31.22B 1,342B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/11/26 | $33.63 | +4.70% | 8,320,493 |
| 30/10/26 | $32.12 | +0.37% | 14,573,303 |
| 29/10/26 | $32.00 | -1.14% | 15,890,551 |
| 28/10/26 | $32.37 | -0.03% | 8,515,390 |
| 27/10/26 | $32.38 | -3.89% | 10,654,943 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- MDLN Stock
Select your edition
All financial news and data tailored to specific country editions
